Infiltration and extravasation

American Journal of Nursing

Volumn 107, Issue 8, 2007, Pages 64-72

  Hadaway, Lynn ^a  

^a Lynn Hadaway Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDOTE; IRRITANT AGENT;

AMPUTATION; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COMPARTMENT SYNDROME; COMPLEX REGIONAL PAIN SYNDROME; CONTRAST MEDIUM EXTRAVASATION; CRYOTHERAPY; DRUG MONITORING; EARLY DIAGNOSIS; EMERGENCY; EPIDEMIOLOGY; FEMALE; HEAT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; PATIENT CARE PLANNING; PRACTICE GUIDELINE; SKIN CARE;

AMPUTATION; ANTIDOTES; CAUSALITY; COMPARTMENT SYNDROMES; COMPLEX REGIONAL PAIN SYNDROMES; CRYOTHERAPY; DRUG MONITORING; EARLY DIAGNOSIS; EMERGENCIES; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HEAT; HUMANS; INFUSIONS, INTRAVENOUS; IRRITANTS; MIDDLE AGED; NURSE'S ROLE; NURSING ASSESSMENT; PATIENT CARE PLANNING; PRACTICE GUIDELINES; SKIN CARE;

EID: 34547573251     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000282299.03441.c7     Document Type: Article

References (35)

1. Infusion Nursing Standards of Practice. J Infus Nurs2006; 29(1 Suppl):S1-S92.
2. Polovich M, et al., editors. Chemotherapy and biotherapy guidelines and recommendations for practice. 2nd ed. Pittsburgh, PA: Oncology Nursing Society; 2005.
3. Kassner E. Evaluation and treatment of chemotherapy extravasation injuries. J Pediatr Oncol Nurs2000;17(3): 135-48.
4. Jacobs JE, et al. Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology1998;209(2):411-6.
5. Schulmeister L, Camp-Sorrell D. Chemotherapy extravasation from implanted ports. Oncol Nurs Forum2000;27(3): 531-8.
6. Kurul S, et al. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 2002; 3(11):684-92.
7. Tiwari A, et al. Acute compartment syndromes. Br J Surg2002;89(4):397-412.
8. Yamaguchi S, Viegas SF. Causes of upper extremity compartment syndrome. Hand Clin1998;14(3):365-70, viii.
9. Willsey DB, Peterfreund RA. Compartment syndrome of the upper arm after pressurized infiltration of intravenous fluid. J Clin Anesth1997;9(5): 428-30.
10. Doro C, et al. Complex regional pain syndrome type I in the upper extremity. Clin Occup Environ Med2006;5(2): 445-54.
11. Institute for Safe Medication Practices. Action needed to prevent serious tissue injury with IV promethazine. The Institute. 2006. http://www.ismp.org/ Newsletters/acutecare/articles/20060810.asp.
12. Kagel EM, Rayan GM. Intravenous catheter complications in the hand and forearm. J Trauma2004;56(1):123-7.
13. Hadaway L. Anatomy and physiology related to intravenous therapy. In: Hankins J, et al., editors. Infusion therapy in clinical practice. 2nd ed. St. Louis: W B. Saunders; 2001.
14. Perdue M. Intravenous complications. In: Hankins J, et al., editors. Infusion therapy in clinical practice. 2nd ed. St. Louis: W. B. Saunders; 2001.
15. Tagalakis V, et al. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med2002; 113(2):146-51.
16. Kuwahara T, et al. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition1998;14(6):496-501.
17. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med1991;114(10): 845-54.
18. Kuwahara T, et al. Experimental infusion phlebitis: tolerance pH of peripheral vein. J Toxicol Sci1999;24(2):113-21.
19. Wood D. A comparative study of two securement techniques for short peripheral intravenous catheters. J Intraven Nurs1997;20(6):280-5.
20. Sheppard K, et al. A prospective study of two intravenous catheter securement techniques in a skilled nursing facility. J Intraven Nurs1999;22(3):151-6.
21. Schears GJ, et al. StatLock catheter securement device significantly reduces central venous catheter complications. In: Patient safety initiative 2000: spotlight on solutions, compendium of successful practices. North Adams, MA: National Patient Safety Foundation; 2000. vol. 1. p. 28-35.
22. Schears GJ. The benefits of a catheter securement device on reducing patient complications: a comprehensive review. Managing Infection Control2005;5(2):14-25.
23. Schears GJ. Summary of product trials for 10,164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs2006;29(4):225-31.
24. The Joint Commission. Behavioral health care restraint and seclusion: restraint and seclusion. 2005. http://www.jointcommission.org/ AccreditationPrograms/Hospitals/Standards/FAQs/Provision+of+Care/ Restraint+and+Seclusion/Restraint_Seclusion.htm.
25. Redelmeier DA, Livesley NJ. Adhesive tape and intravascular-catheter- associated infections. J Gen Intern Med1999;14(6):373-5.
26. San Angel F. Current controversies in chemotherapy administration. J Intraven Nurs1995;18(1):16-23.
27. Dorr RT. Antidotes to vesicant chemotherapy extravasations. Blood Rev1990;4(1):41-60.
28. Schummer W, et al. Extravasation injury in the perioperative setting. Anesth Analg2005;100(3):722-7.
29. Camp-Sorrell D. Developing extravasation protocols and monitoring outcomes. J Intraven Nurs1998;21(4):232-9.
30. Gahart BL, Nazareno AR. Intravenous medications: a handbook for nurses and allied health professionals. 22nd ed. St. Louis: Elsevier Mosby; 2006.
31. Raszka WV, Jr., et al. The use of hyaluronidase in the treatment of intravenous extravasation injuries. J Perinatol1990;10(2):146-9.
32. Schulmeister L. Managing extravasations. Clin J Oncol Nurs2005;9(4):472-5.
33. Hastings-Tolsma MT, et al. Effect of warm and cold applications on the resolution of IV infiltrations. Res Nurs Health1993;16(3):171-8.
34. Yucha CB, et al. Effect of elevation on intravenous extravasations. J Intraven Nurs1994;17(5):231-4.
35. The Joint Commission. Sentinel event policy and procedures. The Commission. 2006. http://www.jointcommission.org/SentinelEvents/ PolicyandProcedures/se_pp.htm.